Magnolia Medical Technologies has developed and tested an innovative means of reducing false-positive blood cultures.

In a study recently published in the Journal of Clinical Microbiology, blood culture contamination rate was reduced by 48% through use of the MMT’s Initial Specimen Diversion Technique (ISDT).

Benefits of implementing ISDT include:

• Improved patient safety by decreasing unnecessary treatments
• Enhanced outcomes based on accurate diagnoses and informed treatment plans
• Reduced incremental expenses associated with erroneous treatments including costly antibiotic therapies and diagnostic imaging
• Increased bed availability and reduction in unnecessary resource consumption

Data about cost impacts of false-positives, as well as links to a number of peer-reviewed medical journal publications that evaluate and analyze patient safety as well as resource consumption implications of contaminated blood cultures are available within this website.